Papel de las sustancias tóxicas en la muerte súbita cardiaca

Bibliographic References

• References 1 J. Lucena, M. Blanco, C. Jurado, A. Rico, M. Salguero, R. Vázquez, et al. Cocaine-related sudden death: a prospective investigation in south-west Spain Eur Heart J, 31 (2010), pp. 318-329
• 2 B. Morentin, J. Ballesteros, L.F. Callado, J.J. Meana Recent cocaine use is a significant risk factor for sudden cardiovascular death in 15–49-year-old subjects: a forensic case–control study Addiction, 109 (2014), pp. 2071-2078
• 3 T. Bjune, B. Risgaard, L. Kruckow, C. Glinge, O. Ingemann-Hansen, P.M. Leth, et al. Post-mortem toxicology in young sudden cardiac death victims: a nationwide cohort study Europace (2017), pp. 1-8
• 4 Observatorio Europeo de las Drogas y las Toxicomanías Informe Europeo sobre Drogas 2016: Tendencias y novedades Oficina de Publicaciones de la Unión Europea, Luxemburgo (2016)
• 5 Plan Nacional sobre Drogas. Informe EDADES 2013. Encuesta sobre alcohol y drogas en España.
• 6 Observatorio Español de la Droga y las Toxicomanías. Estadísticas 2013. Alcohol, tabaco y drogas ilegales en España.
• 7 J.J. de Vreede-Swagemakers, A.P. Gorgels, M.P. Weijenberg, W.I. Dubois-Arbouw, B. Golombeck, J.W. van Ree, et al. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease J Clin Epidemiol, 52 (1999), pp. 601-607
• 8 S.E. Brien, P.E. Ronksley, B.J. Turner, K.J. Mukamal, W.A. Ghali Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies BMJ, 342 (2011), p. d636
• 9 P. Würtz, S. Cook, Q. Wang, M. Tiainen, T. Tynkkynen, A.J. Kangas, et al. Metabolic profiling of alcohol consumption in 9778 young adults Int J Epidemiol, 45 (2016), pp. 506-1493
• 10 C.P. Day, O.F. James, T.J. Butler, R.W. Campbell QT prolongation and sudden cardiac death in patients with alcoholic liver disease Lancet, 341 (1993), pp. 1423-1428
• 11 A. Achaiah, N. Andrews Intoxication with alcohol: an underestimated trigger of Brugada syndrome? JRSM Open, 7 (2016) 2054270416640153
• 12 G. Klein, A. Gardiwal, A. Schaefer, B. Panning, D. Breitmeier Effect of ethanol on cardiac single sodium channel gating Forensic Sci Int, 171 (2007), pp. 131-135
• 13 J. Lucena, P.M. Garamendi, G. Guzzo-Merello, P. Garcia-Pavia Cardiovascular pathology secondary to alcohol consumption, drugs of abuse and medication J. Lucena, P. García-Pavía, M.P. Suárez-Mier, L. Alonso-Pulpón (Eds.), Clinico-pathological atlas of cardiovascular diseases, Springer International Publishing, Switzerland (2015), pp. 299-316
• 14 G. Guzzo-Merello, J. Segovia, F. Dominguez, M. Cobo-Marcos, M. Gomez-Bueno, P. Avellana, et al. Natural history and prognostic factors in alcoholic cardiomyopathy JACC Heart Fail, 31 (2015), pp. 78-86
• 15 A.P. Hallstrom, L.A. Cobb, R. Ray Smoking as a risk factor for recurrence of sudden cardiac arrest N Engl J Med, 314 (1986), pp. 271-275
• 16 S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, et al. Task force on sudden cardiac death of the European Society of Cardiology Eur Heart J, 22 (2001), pp. 1374-1450
• 17 A.P. Burke, A. Farb, G.T. Malcom, Y.H. Liang, J. Smialek, R. Virmani Coronary risk factors and plaque morphology in men with coronary disease who died suddenly N Engl J Med, 336 (1997), pp. 1276-1282
• 18 R.S. Barua, J.A. Ambrose Mechanisms of coronary thrombosis in cigarette smoke exposure Arterioscler Thromb Vasc Biol, 33 (2013), pp. 1460-1467
• 19 L. Afonso, T. Mohammad, D. Thatai Crack whips the heart: a review of the cardiovascular toxicity of cocaine Am J Cardiol, 100 (2007), pp. 1040-1043
• 20 D. Harris, E.T. Everhart, J. Mendelson, R.T. Jones The pharmacology of cocaethylene in humans following cocaine and ethanol administration Drug Alcohol Depend, 72 (2003), pp. 169-182
• 21 D.J. Moliterno, J.E. Willard, R.A. Lange, B.H. Negus, J.D. Boehrer, D.B. Glamann, et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both N Engl J Med, 330 (1994), pp. 454-459
• 22 K. Bachi, V. Mani, D. Jeyachandran, Z.A. Fayad, R.Z. Goldstein, N. Alia-Klein Vascular disease in cocaine addiction Atherosclerosis (2017), 10.1016/j.atherosclerosis.2017.03.019
• 23 R. Virmani, M. Robinowitz, S.E. Smialek, D.F. Smyth Cardiovascular effects of cocaine: an autopsy study of 40 patients Am Heart J, 115 (1988), pp. 1068-1076
• 24 R.B. Dettmeyer Histopathology in drug abuse R.B. Dettmeyes (Ed.), Forensic histopathology. Fundamentals and perspectives, Springer, Berlin/Heidelberg (2011), pp. 67-94
• 25 P.Y. Hsue, C.L. Salinas, A.F. Bolger, N.L. Benowitz, D.D. Waters Acute aortic dissection related to crack cocaine Circulation, 105 (2002), pp. 1592-1595
• 26 C. Palmiere, S. Burkhardt, C. Staub, M. Hallenbarter, G.P. Pizzolato, R. Dettmeyer, et al. Thoracic aortic dissection associated with cocaine abuse Forensic Sci Int, 141 (2004), pp. 137-142
• 27 W.H. Frishman, A. Del Vecchio, S. Sanal, A. Ismail Cardiovascular manifestations of substance abuse. Part 2: alcohol, amphetamines, heroin, cannabis, and caffeine Heart Dis, 5 (2003), pp. 253-271
• 28 M.M. Patel, M.G. Belson, D. Wright, H. Lu, M. Heninger, M.A. Miller Methylenedyoximethamphetamine (ecstasy)-related myocardial hypertrophy: an autopsy study Resuscitation, 66 (2005), pp. 197-202
• 29 S.D. Cohle Fatal coronary artery intimal hyperplasia due to amphetamine use Cardiovasc Pathol, 22 (2013), pp. e1-e4
• 30 E. Turillazi, I. Riezzo Drugs of abuse and pathology of the heart V. Fineschi, G. Baroldi, M.D. Silver (Eds.), Pathology of the heart and sudden death in forensic medicine, CRC Press, Boca Raton, FL (2006), pp. 341-359
• 31 X. Jiao, S. Velez, J. Ringstad, V. Eyma, D. Miller, M. Bleiberg Myocardial infarction associated with Adderall XR and alcohol use in a young man J Am Board Fam Med, 22 (2009), pp. 197-201
• 32 C. Rostagno, S. Caciolli, M. Felici, F. Gori, J.G. Neri Dilated cardiomyopathy associated with chronic consumption of phendimetrazine Am Heart J, 131 (1996), pp. 407-409
• 33 D. Landau, J. Jackson, J. Gonzalez A case of demand ischemia from phendimetrazine Cases J, 1 (2008), p. 105
• 34 T.H. Kang, A. Zhang, H.J. Kim, S.H. Yoo, C.H. Sun, S.D. Lee Acute cardiac death associated with polipharmacy during use of anti-obesity drug Basic Appl Pathol, 1 (2008), pp. 200-202
• 35 E. Jouanjus, V. Raymond, M. Lapeyre-Mestre, V. Wolff What is the current knowledge about the cardiovascular risk for users of cannabis-based products? A systematic review Curr Atheroscler Rep, 19 (2017), p. 26
• 36 B. Hartung, S. Kauferstein, S. Ritz-Timme, T. Daldrup Sudden unexpected death under acute influence of cannabis Forensic Sci Int, 237 (2014), pp. e11-e13
• 37 J. Trecki, R.R. Gerona, M.D. Schwartz Synthetic cannabinoid-related illnesses and deaths N Engl J Med, 373 (2015), pp. 103-107
• 38 A.K. Roy, C. McCarthy, G. Kiernan, C. McGorrian, E. Keenan, N.G. Mahon, et al. Increased incidence of QT interval prolongation in a population receiving lower doses of methadone maintenance therapy Addiction, 107 (2012), pp. 1132-1139
• 39 S.S. Chugh, C. Socoteanu, K. Reinier, J. Waltz, J. Jui, K. Gunson A community-based evaluation of sudden death associated with therapeutic levels of methadone Am J Med, 121 (2008), pp. 66-71
• 40 World Anti-Doping Agency The International Olympic Committee Anti-Doping Rules applicable to the Games of the Olympiad in Rio 2016 WADA, Lausanne (2017), p. 5 Available from: http://www.wada-ama.org/ [accessed 21.04.17]
• 41 World Anti-Doping Agency The World Anti-Doping Code – The 2016 prohibited list, International standard WADA, Lausanne (2016) Available from: http://www.wada-ama.org [accessed 21.04.17]
• 42 R. Melchert, A. Welder Cardiovascular effects of androgenicanabolic steroids Med Sci Sports Exerc, 27 (1995), pp. 1252-1262
• 43 M. Montisci, R. El Mazloum, G. Cecchetto, C. Terranova, S.D. Ferrara, G. Thiene, et al. Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases Forensic Sci Int, 217 (2012), pp. e13-e18
• 44 S. Nottin, L.D. Nguyen, M. Terbah, P. Obert Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue Doppler imaging Am J Cardiol, 97 (2006), pp. 912-915
• 45 B.M. Pluim, A.H. Zwinderman, A. van der Laarse, E.E. van der Wall The athlete's heart. A meta-analysis of cardiac structure and function Circulation, 101 (2000), pp. 336-344
• 46 A. Urhausen, T. Albers, W. Kindermann Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart, 90 (2004), pp. 496-501
• 47 M.A. Sader, K.A. Griffiths, R.J. McCredie, D.J. Handelsman, D.S. Celermajer Androgenic anabolic steroids and arterial structure and function in male bodybuilders J Am Coll Cardiol, 37 (2001), pp. 224-230
• 48 E. Medei, M. Marocolo, D. Rodrigues, P.C. Arantes, C.M. Takiya, J. Silva, et al. Chronic treatment with anabolic steroids induces ventricular repolarization disturbances: cellular, ionic and molecular mechanism J Mol Cell Cardiol, 49 (2010), pp. 165-175
• 49 I. Goldenberg, A.J. Moss Long QT syndrome J Am Coll Cardiol, 51 (2008), pp. 2291-2300
• 50 The Uppsala Monitoring Centre. WHO Collaborating Centre for International Drug Monitoring. Available from: http://www.who-umc.org/DynPage.aspx [accessed 20.04.17].
• 51 W.A. Ray, C.P. Chung, K.T. Murray, K. Hall, C.M. Stein Atypical antipsychotic drugs and the risk of sudden cardiac death N Eng J Med, 360 (2009), pp. 225-235
• 52 P.J. Schwartz, R.L. Woosley Predicting the unpredictable: drug-induced QT prolongation and Torsades de Pointes JACC, 67 (2016), pp. 1639-1650
• 53 C. Antzelevitch, P. Brugada, M. Borggrefe, J. Brugada, R. Brugada, D. Corrado, et al. Brugada syndrome: report of the Second Consensus Conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association Circulation, 111 (2005), pp. 659-670
• 54 A.J. Wood, D.M. Roden Drug-induced prolongation of the QT interval N Eng J Med, 350 (2004), pp. 1013-1022
• 55 Y.G. Yap, A.J. Camm Drug induced QT prolongation and torsades de pointes Heart, 89 (2003), pp. 1363-1372
• 56 W.A. Ray, C.P. Chung, K.T. Murray, K. Hall, C.M. Stein Atypical antipsychotic drugs and the risk of sudden cardiac death N Engl J Med, 360 (2009), pp. 225-235
• 57 E. Findikli, M. Gökçe, V. Nacitarhan, M.A. Camkurt, H.A. Findikli, S. Kardaş, et al. Clin Psychopharmacol Neurosci, 14 (2016), pp. 365-370 58 C. Basso, M. Burke, P. Fornes, P.J. Gallagher, R.H. de Gouveia, M. Sheppard, et al. Guidelines for autopsy investigation of sudden cardiac death Virchows Arch, 452 (2008), pp. 11-18